Latest News

Why goeasy's latest earnings are drawing fresh attention goeasy (TSX:GSY) has moved back into focus after first quarter results showed revenue of CA$412.86 million alongside a net loss of CA$52.99 million, reversing net income reported a year earlier. See our latest analysis for goeasy. The earnings miss and move into a quarterly loss come after a sharp reset in market expectations, with the 90 day share price return down 74.45% and the 1 year total shareholder return down 79.39% despite only...

Kawasaki Heavy Industries (TSE:7012) closed FY 2026 with fourth quarter revenue of ¥749.9 billion and basic EPS of ¥50.61, supported by trailing twelve month EPS of ¥129.41 on revenue of ¥2.3 trillion and year-over-year earnings growth of 22.9%. Over recent periods, the company has seen quarterly revenue range from ¥488.4 billion to ¥749.9 billion, while basic EPS moved between ¥5.08 and ¥52.36 across FY 2026, setting up a picture of earnings that track closely with swings in the top line...

Cambi (OB:CAMBI) has just wrapped up Q1 2026, with investors looking closely at how its recent revenue and earnings run rate sets the tone for the rest of the year. The company posted Q4 2025 revenue of NOK244.7 million and net income of NOK1.4 million, alongside trailing twelve month revenue of NOK1.07 billion and net income of NOK134.7 million, which equated to basic EPS of NOK0.84. Over the last year, the company has seen quarterly revenue range from NOK225.1 million to NOK341.8 million,...

Nippon Avionics (TSE:6946) has rounded out FY 2026 with Q4 revenue of ¥9.5b and basic EPS of ¥107.24, alongside trailing 12 month revenue of ¥29.2b and EPS of ¥253.54 that sit against a 94.5% earnings growth rate over the past year. Over recent periods the company has seen quarterly revenue move from ¥6.5b and EPS of ¥58.26 in FY 2025 Q4 to ¥9.5b and EPS of ¥107.24 in FY 2026 Q4, while trailing net profit margin has improved from 9.8% to 13.1%. This sets up a results season where you will be...

MINEBEA MITSUMI (TSE:6479) has wrapped up FY 2026 with fourth quarter revenue of ¥432.2b and basic EPS of ¥123.63, setting a clear marker for how profitability is tracking against prior periods. The company has seen quarterly revenue move from ¥374.8b in Q4 FY 2025 to ¥432.2b in Q4 FY 2026, while basic EPS shifted from ¥39.35 to ¥123.63 over the same period, giving investors a concrete read on how the earnings line is scaling with the top line. With trailing net margin sitting at 6% versus...

SBI Insurance Group (TSE:7326) has wrapped up FY 2026 with a mixed set of numbers, as fourth quarter revenue came in at ¥35.8b and the company swung to a loss, with EPS declining to ¥517.56 and net income falling to ¥12.8b, while on a trailing 12 month basis EPS stood at ¥116.03 and net income at ¥2.9b. Over recent periods the company has seen revenue move from ¥30.9b in FY 2025 Q4 to ¥35.8b in FY 2026 Q4, alongside quarterly EPS shifting from ¥179.05 to ¥517.56 and trailing 12 month EPS...

Babcock & Wilcox Enterprises (BW) has reported Q1 2026 results with revenue of US$214.4 million and a basic EPS loss of US$0.62, setting a clear marker for how the business is currently trading. Over recent quarters the company has seen revenue move from US$155.8 million in Q1 2025 to US$138.8 million in Q4 2025 and then to US$214.4 million in Q1 2026. Basic EPS shifted from a loss of US$0.18 in Q1 2025 to a loss of US$0.12 in Q4 2025 and then to a loss of US$0.62 this quarter, giving...

Setting the scene on Santen Pharmaceutical's FY 2026 results Santen Pharmaceutical (TSE:4536) has reported a solid finish to FY 2026, with fourth quarter revenue of ¥80.9b and basic EPS of ¥48.36, alongside net income excluding extra items of ¥15,553m. Over the last two reported fourth quarters, revenue has moved from ¥77.2b in FY 2025 to ¥80.9b in FY 2026, while basic EPS shifted from ¥25.74 to ¥48.36 and trailing 12 month EPS stood at ¥114.06 on revenue of ¥291.6b, providing a reference...

Nipro (TSE:8086) has wrapped up FY 2026 with quarterly revenue of ¥173.2b in Q4 and a loss per share of ¥19.50, set against a trailing 12 month EPS of ¥82.80 that reflects a 164.1% earnings change over the past year. Over recent periods, revenue has moved from ¥165.3b in Q4 FY 2025 to ¥173.2b in Q4 FY 2026 while quarterly EPS has swung between a loss of ¥9.08 in Q4 FY 2025 and a profit of ¥66.09 in Q3 FY 2026, leaving investors to weigh a 2% net profit margin for the trailing year against the...

Musashi Seimitsu Industry (TSE:7220) has wrapped up FY 2026 with fourth quarter revenue of ¥94.2b and basic EPS of ¥29.90, alongside net income of ¥2.0b. This gives investors a fresh read on both its top line and bottom line. Over recent periods, revenue has moved from ¥90.6b in FY 2025 Q4 to ¥94.2b in FY 2026 Q4, while basic EPS has shifted from ¥39.90 to ¥29.90. Trailing twelve month EPS stands at ¥19.29 on revenue of ¥347.2b and net income of ¥1.3b, reflecting the impact of thinner margins...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Camtek (NasdaqGM:CAMT) reports exceptionally strong incoming orders tied to advanced semiconductor packaging and AI-driven inspection. The company highlights recent AI-focused deals, including its acquisition of Visual Layer, as a key part of its technology roadmap. Management signals an expectation for more than 25% revenue growth in the second half of 2026, pointing to a step change in demand. For investors tracking NasdaqGM:CAMT, the fresh orders and AI-focused investments add a new...

Coherus Oncology (CHRS) opened Q1 2026 with total revenue of US$12.3 million and a basic EPS loss of US$0.27, presenting a clear picture of a business still in investment mode. Over recent quarters the company reported revenue of US$7.7 million in Q4 2024, US$7.6 million in Q1 2025, US$10.3 million in Q2 2025, US$12.7 million in Q4 2025, and US$12.3 million in the latest quarter. Over the same period, basic EPS losses moved from US$0.40 in Q4 2024 to US$0.41 in Q1 2025, then around US$0.38...

Cosmo Energy Holdings (TSE:5021) has just closed out FY 2026 with fourth quarter revenue of ¥669.5 billion and basic EPS of ¥242.92, capping a trailing twelve month period where revenue came in at ¥2.7 trillion and EPS reached ¥453.06. Over the past few quarters, the company has seen revenue range between ¥648.5 billion and ¥685.2 billion, while basic EPS moved from a quarterly loss of ¥12.33 to ¥242.92, against a backdrop of 28.4% earnings growth over the last year and a net profit margin of...

flyExclusive (FLYX) opened Q1 2026 with total revenue of US$96.4 million and a basic EPS loss of US$0.17, alongside a net income loss of US$7.9 million. These figures put fresh numbers behind a business that is still working through loss-making quarters. The company reported revenue of US$91.4 million in Q4 2024, US$88.1 million in Q1 2025, and US$96.4 million in Q1 2026, while quarterly EPS has remained in loss territory between US$0.17 and US$0.30 over that period. This has kept margins...

Fuji Pharma (TSE:4554) has reported Q2 2026 revenue of ¥13.8b and basic EPS of ¥15.47, with trailing twelve month revenue at ¥57.3b and EPS at ¥98.53 framing the latest quarter against a full year of earnings power. Over recent periods, the company has seen quarterly revenue range from ¥11.1b in Q2 2025 to ¥15.9b in Q1 2026, while basic EPS has moved between ¥12.12 and ¥47.86, giving investors a broad earnings band to measure against the current share price of ¥2,012. With trailing net profit...

Accendra Health (ACH) has kicked off Q1 2026 with revenue of US$627.8 million and a reported loss of US$6.5 million, translating to EPS of US$0.08, while trailing twelve month revenue sits at about US$2.7 billion with a loss of US$105.3 million and EPS of US$1.37. Over recent quarters the company has seen revenue move between US$673.9 million in Q1 2025 and US$709.0 million in Q4 2025, alongside EPS shifting from a loss of US$0.05 in Q1 2025 to a loss of US$0.12 in Q4 2025, before the latest...

Wondering if Essent Group at US$60.87 is still a good deal or already pricing in the story? This article breaks down what the current share price might be implying about value. The stock has been relatively steady, with returns of 1.2% over the past week, 0.6% over the past month, a decline of 5.9% year to date, and a 4.6% return over the last year. The 3 year and 5 year returns sit at 48.5% and 40.5% respectively. Recent coverage around Essent Group has focused on its position within the...

Halozyme Therapeutics (HALO) opened 2026 with Q1 revenue of US$376.7 million and basic EPS of US$1.27, against a backdrop where trailing 12 month revenue sits at about US$1.5 billion and EPS at US$2.94. Over recent quarters, the company has seen revenue move from US$298.0 million in Q4 2024 to US$264.9 million in Q1 2025, then to US$325.7 million in Q2 2025, US$354.3 million in Q3 2025, US$451.8 million in Q4 2025, before the latest US$376.7 million print. Quarterly basic EPS has ranged from...

Paycom Software (NYSE:PAYC) is sponsoring the National Duals Invitational, a new collegiate wrestling event with a $1 million prize pool. The sponsorship links Paycom to a high-profile college sports platform, extending its visibility beyond its payroll and HR software business. This move is intended to deepen community engagement and reach student athletes, fans, and future workforce participants. For investors watching NYSE:PAYC, this sponsorship adds a fresh angle to a story often...

Yokohama Financial Group (TSE:7186) has wrapped up FY 2026 with fourth quarter revenue of ¥102,240 million and basic EPS of ¥19.22, while trailing 12 month revenue reached ¥389,603 million and basic EPS came in at ¥94.03. Over recent periods, revenue has moved from ¥81,314 million in Q4 FY 2025 to ¥102,240 million in Q4 FY 2026, and trailing 12 month net income, excluding extra items, has shifted from ¥82,805 million at Q4 FY 2025 to ¥106,523 million at Q4 FY 2026. This gives investors a...

Tuya (NYSE:TUYA) heads into its Q1 2026 reporting cycle with recent numbers that give investors clear reference points, with Q4 2025 revenue at US$84.5 million and basic EPS of US$0.03 backed by trailing twelve month revenue of US$321.8 million and EPS of US$0.09 versus prior year figures that included smaller profits and an earlier loss. Over the past six quarters, revenue has moved from US$81.6 million in Q3 2024 to US$82.1 million in Q4 2024 and then to US$84.5 million by Q4 2025, while...

Vinci Compass Investments (NasdaqGS:VINP) opened 2026 with Q1 revenue of R$274.9 million and Basic EPS of R$1.57, set against trailing twelve month revenue of R$1.0 billion and Basic EPS of R$4.13 that sit alongside a net margin of 26% and a 105.4% year over year earnings improvement influenced by a R$96.1 million one off gain. Over the past six reported quarters, revenue has ranged from R$234.7 million in Q1 2025 to R$274.9 million in Q1 2026, while quarterly Basic EPS has moved between...

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market fluctuations, investors often find potential opportunities in smaller or newer companies known as penny stocks. Although the term may seem outdated, penny stocks can still offer substantial value by focusing on those with solid financial foundations and growth potential, providing a...